Panacea Biotec Limited Share Price & Technical Analysis
PANACEABIO · ₹419.1 (+0.12%)
Healthcare / Biotechnology
₹419.1
+0.12%
Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. It operates through Vaccines and Pharmaceutical formulations & Nutrition segments. The company's product portfolio includes prescription products in various therapeut…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
16% return in May, -6% avg return in past 3 year May month.
15% return in 2026, 41% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -2% | -10% | -7% | 18% | 16% | – | – | – | – | – | – | – | 15% |
| 25 | -18% | -19% | 48% | 26% | -5% | -16% | -5% | 7% | -2% | 7% | -16% | 2% | 7% |
| 24 | -3% | -8% | -20% | 16% | -8% | 0% | 6% | 57% | 33% | 10% | 28% | -7% | 104% |
| 23 | -10% | -10% | -10% | 10% | -4% | 8% | 3% | 3% | 22% | -10% | 3% | 7% | 13% |
| 22 | 21% | -22% | -25% | 6% | -11% | -14% | -2% | 7% | -5% | 10% | -8% | 2% | -41% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Emerging · Strong
Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. It operates through Vaccines and Pharmaceutical formulations & Nutrition segments. The company's product portfolio includes prescription products in various therapeutic areas, such as oncology, diabetes, gastro-intestinal care, nephrology, orthopedics, pain management, and fever; cold and cough; and betacoronavirus, SARS-CoV-2, typhoid conjugate, pneumococcal conjugate, tetravalent dengue, Mpox, and hepatitis A vaccines, etc. It also offers health supplement products; and paediatric nutrition products under the ChilRunFull, ChilRun 7+, and ChillRun No Sucrose brands. In addition, the company engages in the real estate business. It exports its products to approximately 50 countries. The company has collaboration agreements with the Russian Direct Investment Fund for producing Covid-19 vaccine, and Sputnik-V; and the Indian Council of Medical Research for clinical trials of DengiAll vaccine. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹22.39B
P/E ratio
—
52W high
₹549.7
52W low
₹292.4
Volume
1,81,827
Beta
0.14
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,260
Frequently asked questions
- What is Panacea Biotec Limited share price today?
- Panacea Biotec Limited (PANACEABIO) last traded around ₹419.1 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does PANACEABIO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for PANACEABIO. Download the app for real-time alerts.
- How can I analyze Panacea Biotec Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.